CLINICAL_TRIALS
trial_result
· 2024-11-25
Clinical Trial Update: A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes Patients [Phase 2]
Summary
This Phase 2 trial update reports results from switching Type 2 diabetes patients from a daily DPP-4 inhibitor to HSK7653.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED